LQDA

34.35

1.24% -0.43

Handel nachbörslich: 34.05 -0.30 -0.87%

Liquidia Corp (LQDA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$34.78

Offen:

$34.78

24-Stunden-Volumen:

4.24M

Relative Volume:

0.58

Marktkapitalisierung:

$3.07B

Einnahmen:

$288.07M

Nettoeinkommen (Verlust:

$22.31M

KGV:

242.58

EPS:

0.1416

Netto-Cashflow:

$41.15M

1W Leistung:

+25.46%

1M Leistung:

-49.82%

6M Leistung:

-17.03%

1J Leistung:

+48.19%

1-Tages-Spanne:

$33.33

$34.90

1-Wochen-Bereich:

$26.13

$38.64

52-Wochen-Spanne:

$21.94

$93.61

Liquidia Corp Stock (LQDA) Company Profile

Firmenname

Liquidia Corp

Sektor

Healthcare (1052)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

919.328.4400

Adresse

419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC

Mitarbeiter

216

Twitter

@Liquidia_Inc

Nächster Verdiensttermin

2026-11-02

Neueste SEC-Einreichungen

LQDA's Discussions on Twitter

Compare LQDA vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LQDA Liquidia Corp	34.35	3.07B	288.07M	22.31M	41.15M	0.1416
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-10-14	Hochstufung	BTIG Research	Neutral → Buy
2026-10-02	Herabstufung	Wells Fargo	Overweight → Equal Weight
2026-10-01	Herabstufung	BTIG Research	Buy → Neutral
2026-10-01	Herabstufung	Raymond James	Strong Buy → Outperform
2026-06-29	Herabstufung	BofA Securities	Buy → Neutral
2025-10-20	Eingeleitet	Wells Fargo	Overweight
2025-08-15	Fortgesetzt	Jefferies	Buy
2025-05-19	Herabstufung	Oppenheimer	Perform → Underperform
2024-12-20	Eingeleitet	Wells Fargo	Overweight
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-08-19	Hochstufung	Raymond James	Outperform → Strong Buy
2024-08-16	Eingeleitet	Raymond James	Outperform
2024-06-25	Eingeleitet	Oppenheimer	Perform
2024-01-05	Bestätigt	Needham	Buy
2022-09-19	Fortgesetzt	Wedbush	Underperform
2022-09-01	Herabstufung	Wedbush	Neutral → Underperform
2022-07-22	Eingeleitet	Ladenburg Thalmann	Buy
2022-05-31	Eingeleitet	BTIG Research	Buy
2022-05-26	Eingeleitet	BofA Securities	Buy
2020-12-04	Eingeleitet	H.C. Wainwright	Buy
2020-11-20	Herabstufung	Wedbush	Outperform → Neutral
2018-11-08	Fortgesetzt	Jefferies	Buy
2018-09-05	Eingeleitet	Wedbush	Outperform
2018-08-20	Eingeleitet	Jefferies	Buy
2018-08-20	Eingeleitet	Needham	Buy

Alle ansehen

Liquidia Corp Aktie (LQDA) Neueste Nachrichten

Oct 14, 2026

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label - Zacks Investment Research

Oct 14, 2026

Oct 13, 2026

Liquidia CBO Jason Adair sells $207,932 in shares after vesting - Investing.com

Oct 13, 2026

Liquidia Corp general counsel Schundler sells $389,948 of stock - Investing.com

Oct 13, 2026

Liquidia CCO Scott Moomaw sells $252,418 in company stock By Investing.com - Investing.com India

Oct 13, 2026

To cover stock-award taxes, Liquidia (LQDA) general counsel sells 13,692 shares at $28.48 each. - Stock Titan

Oct 13, 2026

Scott Moomaw Disposes 8,863 Shares of Liquidia Corp (LQDA) Following PSU Vesting on October 12, 2026 - Kalkine Media

Oct 13, 2026

Liquidia Corp's Rajeev Saggar Converts PSUs and Sells 9,218 Shares on October 12, 2026 - Kalkine Media

Oct 13, 2026

Liquidia Corp CBO Jason Adair Sells 7,301 Shares at $28.48 Following RSU and PSU Vesting in October 2026 - Kalkine Media

Oct 13, 2026

To cover stock-award taxes, Liquidia (LQDA) CFO and COO Kaseta sold 18,938 shares at $28.48 each. - Stock Titan

Oct 13, 2026

A tax-related sale at Liquidia (LQDA) totals 1,101 shares at $28.48 each. - Stock Titan

Oct 13, 2026

To cover stock-award taxes, Liquidia (LQDA) CEO Roger Jeffs sold 32,744 shares. - Stock Titan

Oct 13, 2026

To cover award taxes, Dana Boyle sells 5,892 Liquidia (LQDA) shares at $28.48 each. - Stock Titan

Oct 13, 2026

Oct 07, 2026

Stephen M. Bloch Sells 235,477 Liquidia Shares via Canaan VIII L.P. at $27.13 Average Price - Kalkine Media

Oct 07, 2026

Liquidia director Stephen Bloch sells $6.39m in shares - Investing.com

Oct 07, 2026

LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Oct 07, 2026

Oct 01, 2026

Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback - Zacks Investment Research

Oct 01, 2026

UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - Zacks Investment Research

Oct 01, 2026

Sep 29, 2026

Liquidia Corporation (LQDA) Stock Price & News - Syfe

Sep 29, 2026

Sep 15, 2026

Option exercises and share sales by Liquidia (NASDAQ: LQDA) director - Stock Titan

Sep 15, 2026

Sep 12, 2026

Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat

Sep 12, 2026

Sep 11, 2026

Director at Liquidia (NASDAQ: LQDA) plans $619K stock sale - Stock Titan

Sep 11, 2026

LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Yahoo Finance

Sep 11, 2026

Liquidia Corporation $LQDA Holdings Decreased by Opaleye Management Inc. - MarketBeat

Sep 11, 2026

Sep 10, 2026

Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio? - Yahoo Finance

Sep 10, 2026

Sep 09, 2026

Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com India

Sep 08, 2026

Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com

Sep 08, 2026

Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com UK

Sep 08, 2026

Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA - MarketBeat

Sep 08, 2026

Sep 06, 2026

Liquidia Corp Stock Intrinsic Values - GuruFocus

Sep 06, 2026

Sep 04, 2026

Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)? - Yahoo Finance

Sep 04, 2026

Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation? - Yahoo Finance

Sep 04, 2026

Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks - Yahoo Finance

Sep 04, 2026

Sep 03, 2026

Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com

Sep 03, 2026

Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media

Sep 03, 2026

How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media

Sep 03, 2026

Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga

Sep 03, 2026

Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance

Sep 03, 2026

LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus

Sep 03, 2026

Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative

Sep 03, 2026

Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan

Sep 03, 2026

Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - MarketBeat

Sep 03, 2026

Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Sep 03, 2026

Sep 02, 2026